Ona Therapeutics scores Series A

Barcelona-based Ona Therapeutics, which is focused on treating metastatic cancer, has raised 30 million euros in Series A financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this